Nissor Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2015.
2015 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Nissor Pharmaceuticals Limited

Nissor Pharmaceuticals Limited, a active public limited company, was established on 08 May 2015 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900MH2015PLC264184. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Manish Pitambar Satia (Director), Berkha Pitamber Satia (Director), Vansh Hasmukh Jain (Director). Past directors included Berkha Pitamber Satia, Vansh Hasmukh Jain, Pitambar Thakurdas Satia. It holds ₹6.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Shop No. 8, Ground Floor, Plot 40, Shilpin Centre, G. D. Ambekar Marg, Wadala,, Mumbai, Maharashtra, 400031.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900MH2015PLC264184

  • Registration Number

    264184

  • Incorporation Date

    08 May 2015

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 10 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 6.00 M
  • Revenue Growth **** -41.22%
  • Profit Growth **** -4.58%
  • Ebitda **** 8.36%
  • Net Worth 51.98%
  • Total Assets **** 0.16%
Company report

Nissor Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nissor Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Nissor Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Manish Pitambar Satia Director 08 May 2015 Current
Berkha Pitamber Satia Director 10 Aug 2020 Current
Vansh Hasmukh Jain Director 01 Mar 2019 Current
Jeet Jain Champalal Director 08 May 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 27 Jan 2020 Past
Pramod Abcsdd Director 08 Jan 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nissor Pharmaceuticals.

Nissor Pharmaceuticals Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 41.22% decrease. The company also saw a slight decrease in profitability, with a 4.58% decrease in profit. The company's net worth Soared by an impressive increase of 51.98%.

Nissor Pharmaceuticals revenue growth over time
Nissor Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -41.22%
*******
*******
*******
*******
Revenue from Operations
*******
 -41.18%
*******
*******
*******
*******
Total Assets
*******
 0.16%
*******
*******
*******
*******
Profit or Loss
*******
 -4.58%
*******
*******
*******
*******
Net Worth
*******
 51.98%
*******
*******
*******
*******
EBITDA
*******
 8.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nissor Pharmaceuticals?

In 2021, Nissor Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹6,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.60 Cr
Latest Charge Details
Date Lender Amount Status
29 Sep 2018 Others ₹6.00 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Nissor Pharmaceuticals?

Unlock and access historical data on people associated with Nissor Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nissor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nissor Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nissor Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Nissor Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Nissor Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Berkha Pitamber Satia was appointed as a Director was appointed as a Director on 10 Aug 2020 & has been associated with this company since 5 years 6 months . was completed.

  • Director Appointment

    Vansh Hasmukh Jain was appointed as a Director was appointed as a Director on 01 Mar 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 6.00 M with Charge ID 100241616 was registered on 29 Sep 2018. was documented.

  • Director Appointment

    The activity Manish Pitambar Satia was appointed as a Director was appointed as a Director on 08 May 2015 & has been associated with this company since 10 years 9 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nissor Pharmaceuticals Limited?

The CIN of Nissor Pharmaceuticals Limited is U74900MH2015PLC264184.

Where is Nissor Pharmaceuticals Limited headquartered?

Nissor Pharmaceuticals Limited is headquartered at Shop No. 8, Ground Floor, Plot 40, Shilpin Centre, G. D. Ambekar Marg, Wadala,, Mumbai, Maharashtra, 400031.

When was Nissor Pharmaceuticals Limited incorporated?

Nissor Pharmaceuticals Limited was incorporated on 08 May 2015.

Who are the current directors of Nissor Pharmaceuticals Limited?

The current directors of Nissor Pharmaceuticals Limited are

What is the primary industry of Nissor Pharmaceuticals Limited?

The primary industry of Nissor Pharmaceuticals Limited is Trade.

Is Nissor Pharmaceuticals Limited a listed company?

Nissor Pharmaceuticals Limited is unlisted.

What is the capital structure of Nissor Pharmaceuticals Limited?

The authorized capital of Nissor Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Nissor Pharmaceuticals Limited?

The compliance status of Nissor Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available